SIGA TECHNOLOGIES INC

SIGA is the ticker symbol for SIGA TECHNOLOGIES INC, a publicly traded US company.

SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.

Key metrics include a return on equity of -2.3%, a debt-to-equity ratio of 0.45.

The company reports trailing twelve-month revenue of $4.26M and net loss of $3.45M.

FINOTAUR aggregates real-time and fundamental data on SIGA to help traders and investors make informed decisions. Track SIGA in your trading journal alongside other positions for a unified view of your portfolio.